Johnson & Johnson TALVEY — Percent Change (as a percent) increased by 1178.3% to 76.7% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 58.5%, from 48.4% to 76.7%. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates accelerating growth, while a negative percentage suggests a slowdown in product adoption or market share loss.
This metric measures the period-over-period percentage growth or decline in net sales for the TALVEY product line. It pr...
Comparable to revenue growth rate disclosures for specific drug franchises or product lines across the biopharmaceutical industry.
jnj_segment_talvey_percent_change_as_a_percent| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | 48.4% | 55% | 60.8% | 6% | 76.7% |
| QoQ Change | — | +13.6% | +10.5% | -90.1% | >999% |
| YoY Change | — | — | — | — | +58.5% |